 |
 |
 |
 |
|
 |
Previous 25 Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
 |
Boston, MA Bethesda, MD Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Seattle, WA |
 |
11/08/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
 |
Houston, TX |
 |
10/27/2008 |
 |
 |
 |
Details |
 |
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
 |
Los Angeles, CA San Francisco, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI |
 |
10/27/2008 |
 |
 |
 |
 |
 |
Details |
 |
BIBW 2992 with or without daily temozolomide in the treatment of
patients with recurrent malignant glioma
|
 |
Charlottesville, VA |
 |
10/20/2008 |
 |
 |
 |
Details |
 |
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
 |
Boston, MA New York, NY Houston, TX Charlottesville, VA |
 |
10/09/2008 |
 |
 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Charlottesville, VA |
 |
09/30/2008 |
 |
 |
 |
Details |
 |
Gliogene: An International Brain Tumor Study |
 |
Houston, TX |
 |
07/24/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
 |
Houston, TX |
 |
05/28/2008 |
 |
 |
 |
Details |
 |
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
 |
Houston, TX |
 |
05/28/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme |
 |
Houston , TX |
 |
04/27/2008 |
 |
 |
 |
Details |
 |
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
 |
Houston, TX |
 |
04/15/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
 |
Houston, TX |
 |
04/15/2008 |
 |
 |
 |
Details |
 |
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
Los Angeles, CA Boston, MA Durham, NC New York, NY Houston, TX |
 |
04/15/2008 |
 |
 |
 |
 |
 |
Details |
 |
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma |
 |
Houston, TX |
 |
04/15/2008 |
 |
 |
 |
Details |
 |
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
 |
Pittsburgh, PA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Kingston, Ontario, CANADA Edmonton, Alberta, CANADA Moncton, New Brunswick, CANADA Ottawa, Ontario, CANADA Toronto, Ontario, CANADA Winnipeg, Manitoba, CANADA Phoenix, AZ La Jolla, CA Palo Alto, CA Sacramento, CA Aurora, CO Englewood, CO Jacksonville, FL Orlando, FL Chicago, IL Evanston, IL Boston, MA Detroit, MI Winston-Salem, NC Edison, NJ Buffalo, NY Columbus, OH Columbus, OH Portland, OR Memphis, TN Nashville, TN Seattle, WA Madison, WI |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
Gliogene: Brain Tumor Linkage Study |
 |
San Francisco, CA Tampa, FL Boston, MA New York, NY Houston, Tx |
 |
01/17/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
 |
San Francisco, CA |
 |
01/17/2008 |
 |
 |
 |
Details |
 |
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
 |
 |